News Hub

Introducing New ISCT Chief Scientific Officer Dr. Rachele Ciccocioppo, MD

ISCT is pleased to introduce our new ISCT Chief Scientific Officer Dr. Rachele Ciccocioppo. 

As CSO, Dr. Ciccocioppo will represent the academic pillar of the Society and be the leadership voice of the scientific committees within ISCT.  

Rachele Ciccocioppo, MD

ISCT Chief Scientific Officer
University of Verona

Verona, Italy

Rachele Ciccocioppo is Associate Professor of Gastroenterology at the Department of Medicine, AOUI Policlinico GB Rossi & University of Verona (Italy). After graduation as Medical Doctor, she achieved specialization in both Gastroenterology and Digestive Endoscopy, and Internal Medicine. She was Academic Visitor and Research Associate at the Department of Neurophysiology of The Flinders University of Adelaide (South Australia), and at the Research Laboratories of the Department of Internal Medicine of the University of Erlangen-Nürberg (Germany). Since 2016: Member of the International Society for Cell & Gene Therapy (ISCT) and co-founder and co-chair of the Gastrointestinal Committee. She has been Deputy Chief Scientific Officer of ISCT since 2020. She was invited speaker in many national and international congresses, and referee for many scientific journals in the field of clinical and experimental Gastroenterology, Immunology, cell therapy and regenerative medicine based. She is co-author of approximately 150 papers, 300 abstracts presented at national and international congresses and 15 scientific book chapters. She was Coordinator or Head of Research Unit in several cooperative projects, both Italian and International, and Principal Investigator in several multicentre clinical trials on the study of new therapeutic tools in inflammatory bowel diseases. Her main fields of interest are: biology and clinical application of mesenchymal stem/stromal cells, management of chronic inflammatory enteropathies; opportunistic infections in Gastroenterology.